Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
| Title: | Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma |
|---|---|
| Authors: | Manson, G.Aff1; Brice, P.Aff2; Herbaux, C.Aff3; Silva, M. G.Aff4; Bouabdallah, K.Aff5; Deau, B.Aff6; Bouteloup, J.Aff7; Schiano, J. M.Aff8; Nicolas-Virelizier, E.Aff9; Maerevoet, M.Aff10; Ghesquieres, H.Aff11; Stamatoullas, A.Aff12; Antier, C.Aff13; Carlo-Stella, C.Aff14, Aff15; de Charette, M.Aff3; Poizeau, F.Aff16, Aff17; Dercle, L.Aff18, Aff19; Houot, RochAff1, IDs00259020050152_cor18 |
| Source: | European Journal of Nuclear Medicine and Molecular Imaging. 48(4):1144-1153 |
| Database: | Springer Nature Journals |